MHRAapproval72% confidence
Clinical trials for medicines: modifying a clinical trial approval
Source: MHRA
Why This Matters
Why this matters: illustrates how regulators handled a comparable approval decision relevant to Novo Nordisk.
Regulatory Analysis
Guidance on the various types of modifications that can be made to a clinical trial approval.
Supporting Context
- Therapeutic area
- Endocrinology · Type 2 Diabetes
- Sub-indication
- General
Related signal: Novo Nordisk Tests UBT251 for Type 2 Diabetes in New Clinical Trial